Regulation of neural enzymes
US6365573B1 · kind B1 · utility
7Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 10, 1999 |
| Grant date | Apr 2, 2002 |
| Priority date | — |
| Expiry date | May 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the use of the tripeptide Gly-Pro-Glu (GPE) or analogs thereof for the treatment of conditions of the central nervous system (e.g. cerebral vasculitis) in which the amount of the neural enzymes nitric oxide synthetase (NOS) and/or glutamic acid decarboxylase (GAD) is reduced.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.